163 related articles for article (PubMed ID: 15228377)
1. A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point.
Williams P; Reeder CE
J Manag Care Pharm; 2004; 10(3):259-65. PubMed ID: 15228377
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
Williams P; Reeder CE
Clin Ther; 2003 Nov; 25(11):2903-19. PubMed ID: 14693315
[TBL] [Abstract][Full Text] [Related]
3. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
McCormack PL; Foster RH
Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
Zhang L; Hay JW
CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898
[TBL] [Abstract][Full Text] [Related]
5. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours.
Adelman JU; Belsey J
J Manag Care Pharm; 2003; 9(1):45-52. PubMed ID: 14613361
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on almotriptan in migraine.
Keam SJ; Goa KL; Figgitt DP
CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
[TBL] [Abstract][Full Text] [Related]
8. A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.
Mondell BE
Clin Ther; 2003 Feb; 25(2):331-41. PubMed ID: 12749502
[TBL] [Abstract][Full Text] [Related]
9. Almotriptan: a review of its use in migraine.
Keam SJ; Goa KL; Figgitt DP
Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
[TBL] [Abstract][Full Text] [Related]
10. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.
Dodick DW; Sandrini G; Williams P
CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530
[TBL] [Abstract][Full Text] [Related]
11. Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan.
Wang JT; Barr CE; Goldfarb SD
Headache; 2002 Jan; 42 Suppl 1():38-43. PubMed ID: 11966863
[TBL] [Abstract][Full Text] [Related]
12. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
14. Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms.
Mannix LK; Adelman JU; Goldfarb SD; Von S; Kozma CM
Am J Manag Care; 2002 Feb; 8(3 Suppl):S94-101. PubMed ID: 11859910
[TBL] [Abstract][Full Text] [Related]
15. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
16. Oral almotriptan in the treatment of migraine: safety and tolerability.
Dodick DW
Headache; 2001 May; 41(5):449-55. PubMed ID: 11380642
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of almotriptan malate for migraine.
Balbisi EA
Am J Health Syst Pharm; 2002 Nov; 59(22):2184-93. PubMed ID: 12455302
[TBL] [Abstract][Full Text] [Related]
19. Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
Dodick DW
Headache; 2002 Jan; 42(1):21-7. PubMed ID: 12005271
[TBL] [Abstract][Full Text] [Related]
20. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
Mayo KW; Osterhaus JT
Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
